Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

Regeneron (REGN) came out with quarterly earnings of $12.89 per share, beating the Zacks Consensus Estimate of $8.03 per ...

(Reuters) -Regeneron Pharmaceuticals beat Wall Street estimates for second-quarter revenue and profit on Friday helped by ...

To align with global demand and the company's planned maintenance, LYB expects third quarter operating rates of 85% for North ...

Donald Trump has asked major pharmaceutical companies to lower US drug prices. He wants them to match the prices paid in ...

Alnylam Pharmaceuticals, Inc. shares soar with strong Q2 results, driven by Amvuttra's stellar U.S. launch for ATTR ...

Mediolanum International Funds Ltd has supercharged its investment in Regeneron Pharmaceuticals, increasing its stake by a ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, ...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like ...

The investment is highlighted by a state-of-the-art API facility in Virginia and expansions across multiple states.

It’s Friday, which means another edition of AM Extra’s Cin-Emma Extra with our resident movie buff Emma Jerome.